(SFM) Sprouts Farmers Market - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US85208M1027
Stock: Fresh Produce, Meat, Seafood, Dairy, Supplements
Total Rating 36
Risk 66
Buy Signal -0.30
| Risk 5d forecast | |
|---|---|
| Volatility | 36.4% |
| Relative Tail Risk | -9.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.21 |
| Alpha | -62.03 |
| Character TTM | |
|---|---|
| Beta | 0.818 |
| Beta Downside | 1.304 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.48% |
| CAGR/Max DD | 0.49 |
EPS (Earnings per Share)
Revenue
Description: SFM Sprouts Farmers Market March 05, 2026
Sprouts Farmers Market, Inc. (SFM) is a U.S. food retailer specializing in fresh, natural, and organic products. The company emphasizes lifestyle-friendly ingredients like organic, plant-based, and gluten-free options, catering to a growing consumer demand for health-conscious food choices.
SFMs product categories span both perishable goods, such as produce and meat alternatives, and non-perishable items, including groceries, supplements, and frozen foods. This broad offering aligns with the typical supermarket business model, but with a focus on a niche market segment within the food retail sector.
For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Organic food demand fuels revenue growth
- Supply chain costs impact profit margins
- New store openings drive market expansion
- Commodity price fluctuations affect inventory costs
- Competition from mainstream grocers pressures pricing
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 523.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -0.19 > 1.0 |
| NWC/Revenue: -0.69% < 20% (prev -0.06%; Δ -0.63% < -1%) |
| CFO/TA 0.17 > 3% & CFO 714.4m > Net Income 523.7m |
| Net Debt (1.69b) to EBITDA (885.4m): 1.90 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (97.5m) vs 12m ago -3.79% < -2% |
| Gross Margin: 38.35% > 18% (prev 0.38%; Δ 3.80k% > 0.5%) |
| Asset Turnover: 225.8% > 50% (prev 212.0%; Δ 13.79% > 0%) |
| Interest Coverage Ratio: 259.1 > 6 (EBITDA TTM 885.4m / Interest Expense TTM 2.66m) |
Altman Z'' 1.74
| A: -0.01 (Total Current Assets 809.9m - Total Current Liabilities 870.8m) / Total Assets 4.16b |
| B: 0.13 (Retained Earnings 561.1m / Total Assets 4.16b) |
| C: 0.18 (EBIT TTM 688.9m / Avg Total Assets 3.90b) |
| D: 0.20 (Book Value of Equity 561.2m / Total Liabilities 2.76b) |
| Altman-Z'' Score: 1.74 = BBB |
Beneish M -2.68
| DSRI: 1.44 (Receivables 65.2m/39.7m, Revenue 8.81b/7.72b) |
| GMI: 1.00 (GM 38.35% / 38.37%) |
| AQI: 0.89 (AQ_t 0.15 / AQ_t-1 0.17) |
| SGI: 1.14 (Revenue 8.81b / 7.72b) |
| TATA: -0.05 (NI 523.7m - CFO 714.4m) / TA 4.16b) |
| Beneish M-Score: -2.68 (Cap -4..+1) = A |
What is the price of SFM shares?
As of March 14, 2026, the stock is trading at USD 75.35 with a total of 1,686,122 shares traded.
Over the past week, the price has changed by +2.26%, over one month by +19.00%, over three months by +2.08% and over the past year by -38.57%.
Over the past week, the price has changed by +2.26%, over one month by +19.00%, over three months by +2.08% and over the past year by -38.57%.
Is SFM a buy, sell or hold?
Sprouts Farmers Market has received a consensus analysts rating of 3.60.
Therefor, it is recommend to hold SFM.
- StrongBuy: 4
- Buy: 1
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SFM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92.1 | 22.2% |
| Analysts Target Price | 92.1 | 22.2% |
SFM Fundamental Data Overview March 13, 2026
P/E Trailing = 14.3798
P/E Forward = 13.5135
P/S = 0.8331
P/B = 5.0791
P/EG = 1.0397
Revenue TTM = 8.81b USD
EBIT TTM = 688.9m USD
EBITDA TTM = 885.4m USD
Long Term Debt = 1.94b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 179.3m USD (from shortTermDebt, last quarter)
Debt = 1.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.69b USD (from netDebt column, last quarter)
Enterprise Value = 9.02b USD (7.34b + Debt 1.94b - CCE 257.3m)
Interest Coverage Ratio = 259.1 (Ebit TTM 688.9m / Interest Expense TTM 2.66m)
EV/FCF = 19.36x (Enterprise Value 9.02b / FCF TTM 466.1m)
FCF Yield = 5.17% (FCF TTM 466.1m / Enterprise Value 9.02b)
FCF Margin = 5.29% (FCF TTM 466.1m / Revenue TTM 8.81b)
Net Margin = 5.95% (Net Income TTM 523.7m / Revenue TTM 8.81b)
Gross Margin = 38.35% ((Revenue TTM 8.81b - Cost of Revenue TTM 5.43b) / Revenue TTM)
Gross Margin QoQ = 36.16% (prev 38.68%)
Tobins Q-Ratio = 2.17 (Enterprise Value 9.02b / Total Assets 4.16b)
Interest Expense / Debt = 0.04% (Interest Expense 814k / Debt 1.94b)
Taxrate = 27.36% (33.8m / 123.7m)
NOPAT = 500.5m (EBIT 688.9m * (1 - 27.36%))
Current Ratio = 0.93 (Total Current Assets 809.9m / Total Current Liabilities 870.8m)
Debt / Equity = 1.39 (Debt 1.94b / totalStockholderEquity, last quarter 1.40b)
Debt / EBITDA = 1.90 (Net Debt 1.69b / EBITDA 885.4m)
Debt / FCF = 3.62 (Net Debt 1.69b / FCF TTM 466.1m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.43% (Net Income 523.7m / Total Assets 4.16b)
RoE = 38.21% (Net Income TTM 523.7m / Total Stockholder Equity 1.37b)
RoCE = 20.79% (EBIT 688.9m / Capital Employed (Equity 1.37b + L.T.Debt 1.94b))
RoIC = 36.52% (NOPAT 500.5m / Invested Capital 1.37b)
WACC = 7.07% (E(7.34b)/V(9.28b) * Re(8.93%) + D(1.94b)/V(9.28b) * Rd(0.04%) * (1-Tc(0.27)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.31%
[DCF] Terminal Value 82.70% ; FCFF base≈445.6m ; Y1≈486.0m ; Y5≈612.0m
[DCF] Fair Price = 119.5 (EV 12.99b - Net Debt 1.69b = Equity 11.31b / Shares 94.6m; r=7.07% [WACC]; 5y FCF grow 10.34% → 2.90% )
EPS Correlation: 65.15 | EPS CAGR: 4.15% | SUE: 0.23 | # QB: 0
Revenue Correlation: 94.67 | Revenue CAGR: 7.45% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.37 | Chg7d=+0.011 | Chg30d=-0.102 | Revisions Net=-6 | Analysts=10
EPS current Year (2026-12-31): EPS=5.58 | Chg7d=+0.026 | Chg30d=-0.193 | Revisions Net=-8 | Growth EPS=+5.0% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=5.97 | Chg7d=-0.025 | Chg30d=-0.456 | Revisions Net=-8 | Growth EPS=+7.0% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 8.9% - Earnings Yield 7.0%)
[Growth] Growth Spread = +2.8% (Analyst 4.8% - Implied 2.0%)
P/E Forward = 13.5135
P/S = 0.8331
P/B = 5.0791
P/EG = 1.0397
Revenue TTM = 8.81b USD
EBIT TTM = 688.9m USD
EBITDA TTM = 885.4m USD
Long Term Debt = 1.94b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 179.3m USD (from shortTermDebt, last quarter)
Debt = 1.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.69b USD (from netDebt column, last quarter)
Enterprise Value = 9.02b USD (7.34b + Debt 1.94b - CCE 257.3m)
Interest Coverage Ratio = 259.1 (Ebit TTM 688.9m / Interest Expense TTM 2.66m)
EV/FCF = 19.36x (Enterprise Value 9.02b / FCF TTM 466.1m)
FCF Yield = 5.17% (FCF TTM 466.1m / Enterprise Value 9.02b)
FCF Margin = 5.29% (FCF TTM 466.1m / Revenue TTM 8.81b)
Net Margin = 5.95% (Net Income TTM 523.7m / Revenue TTM 8.81b)
Gross Margin = 38.35% ((Revenue TTM 8.81b - Cost of Revenue TTM 5.43b) / Revenue TTM)
Gross Margin QoQ = 36.16% (prev 38.68%)
Tobins Q-Ratio = 2.17 (Enterprise Value 9.02b / Total Assets 4.16b)
Interest Expense / Debt = 0.04% (Interest Expense 814k / Debt 1.94b)
Taxrate = 27.36% (33.8m / 123.7m)
NOPAT = 500.5m (EBIT 688.9m * (1 - 27.36%))
Current Ratio = 0.93 (Total Current Assets 809.9m / Total Current Liabilities 870.8m)
Debt / Equity = 1.39 (Debt 1.94b / totalStockholderEquity, last quarter 1.40b)
Debt / EBITDA = 1.90 (Net Debt 1.69b / EBITDA 885.4m)
Debt / FCF = 3.62 (Net Debt 1.69b / FCF TTM 466.1m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.43% (Net Income 523.7m / Total Assets 4.16b)
RoE = 38.21% (Net Income TTM 523.7m / Total Stockholder Equity 1.37b)
RoCE = 20.79% (EBIT 688.9m / Capital Employed (Equity 1.37b + L.T.Debt 1.94b))
RoIC = 36.52% (NOPAT 500.5m / Invested Capital 1.37b)
WACC = 7.07% (E(7.34b)/V(9.28b) * Re(8.93%) + D(1.94b)/V(9.28b) * Rd(0.04%) * (1-Tc(0.27)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.31%
[DCF] Terminal Value 82.70% ; FCFF base≈445.6m ; Y1≈486.0m ; Y5≈612.0m
[DCF] Fair Price = 119.5 (EV 12.99b - Net Debt 1.69b = Equity 11.31b / Shares 94.6m; r=7.07% [WACC]; 5y FCF grow 10.34% → 2.90% )
EPS Correlation: 65.15 | EPS CAGR: 4.15% | SUE: 0.23 | # QB: 0
Revenue Correlation: 94.67 | Revenue CAGR: 7.45% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.37 | Chg7d=+0.011 | Chg30d=-0.102 | Revisions Net=-6 | Analysts=10
EPS current Year (2026-12-31): EPS=5.58 | Chg7d=+0.026 | Chg30d=-0.193 | Revisions Net=-8 | Growth EPS=+5.0% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=5.97 | Chg7d=-0.025 | Chg30d=-0.456 | Revisions Net=-8 | Growth EPS=+7.0% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 8.9% - Earnings Yield 7.0%)
[Growth] Growth Spread = +2.8% (Analyst 4.8% - Implied 2.0%)